0.05 ML aflibercept 40 MG/ML Injection [Eylea]

Known as: aflibercept 40 mg in 1 mL INTRAVITREAL INJECTION, SOLUTION [EYLEA], Eylea 2 MG per 0.05 ML Intravitreal Injection, EYLEA 2 MG in 0.05 ML Injection 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
PURPOSE To identify the spectral domain optical coherence tomography predictors of visual prognosis in retinal vein occlusion… (More)
Is this relevant?
2018
2018
PURPOSE to explore whether the NK1 and Y2 receptors are involved in the pathogenesis of laser-induced CNV (choroidal… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Le traitement de la forme exsudative de la dégénérescence maculaire liée à l’âge repose en France sur les injections intravitr… (More)
Is this relevant?
2016
2016
Background: We sought to verify the efficacy and safety of transconjunctival 23-gauge pars plana vitrectomy (PPV) alone by our… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Review
2015
Review
2015
PURPOSE To evaluate the outcomes of different types of treatment of chronic cystoid macular edema (CME) after pars plana… (More)
Is this relevant?
2014
2014
O peptides and proteins remain a significant challenge for sustained or controlled delivery. Many of these agents have been… (More)
Is this relevant?
2014
2014
EΓΧEΙΡΗΣΗ ΚΑΤΑΡΡΑΚΤΗ αντι VEGF παράγοντeς. Διάγνωση και EΓΧEΙΡΗΣΗ ΚΑΤΑΡΡΑΚΤΗ και αντι VEGF παράγοντeς . 
Is this relevant?
2013
2013
La nouvelle est encore chaude, extraite du Journal Officiel du 30 octobre [1] : l'Eylea® recoit son AMM (Autorisation de mise en… (More)
Is this relevant?